Related Experiment Videos

Thallium-201 myocardial scintigraphy during dipyridamole-induced coronary hyperaemia. First experiences with a new

P V Madsen1, O Munck, H Kelbaek

  • 1Surgical Department H, Gentofte Hospital, Denmark.

Danish Medical Bulletin
|December 1, 1988
PubMed

Insights

Preoperative thallium-201 dipyridamole myocardial scintigraphy detected significant coronary artery disease in all patients with severe peripheral atherosclerosis undergoing surgery. This noninvasive imaging is crucial for identifying silent ischemic heart disease.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Vascular Surgery

Background:

  • Severe peripheral vascular atherosclerosis often coexists with coronary artery disease.
  • Patients undergoing abdominal aortic surgery may have undiagnosed ischemic heart disease.
  • Standard exercise tests are often not feasible in this patient population.

Purpose of the Study:

  • To evaluate the utility of thallium-201 dipyridamole myocardial scintigraphy in detecting coronary artery disease in patients with severe peripheral vascular atherosclerosis.
  • To assess the prevalence of silent ischemic heart disease in patients scheduled for abdominal aortic surgery.

Main Methods:

  • Eight patients with severe peripheral vascular atherosclerosis awaiting abdominal aortic surgery were prospectively studied.
  • Preoperative noninvasive assessment using thallium-201 dipyridamole myocardial scintigraphy was performed.
  • Serum cardiac biomarkers (creatine kinase, aspartate aminotransferase, lactate dehydrogenase) were monitored postoperatively.

Main Results:

  • All eight patients exhibited abnormal preoperative myocardial scintigraphy, indicating myocardial scar and/or ischemia.
  • Postoperative elevation of creatine kinase occurred in seven patients.
  • Two patients showed elevated aspartate aminotransferase and lactate dehydrogenase levels.
  • No patient presented with clinical or electrocardiographical evidence of acute myocardial infarction.

Conclusions:

  • Thallium-201 dipyridamole myocardial scintigraphy is a valuable noninvasive tool for detecting ischemic heart disease in patients with severe peripheral atherosclerosis.
  • This imaging modality is particularly useful for patients unable to undergo exercise stress testing.
  • The precise determination of regional washout in myocardial scintigraphy aids in identifying ischemia, especially with low washout values.

Related Concept Videos